ReviewClinical Medicine Insights. Oncology2022

Immunotherapy With Checkpoint Inhibitors in FGFR-Altered Urothelial Carcinoma.

David J Benjamin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.